Clinical Trial Update: Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity [Phase 4]

View source ↗

Summary

Phase 4 trial update examining dose reduction for early rheumatoid arthritis patients with low disease activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Karolinska Institutet | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN